A detailed history of Lincoln National Corp transactions in Novartis Ag stock. As of the latest transaction made, Lincoln National Corp holds 10,302 shares of NVS stock, worth $1.11 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,302
Previous 10,826 4.84%
Holding current value
$1.11 Million
Previous $1.09 Million 8.87%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$95.27 - $108.47 $49,921 - $56,838
-524 Reduced 4.84%
10,302 $996,000
Q4 2023

Feb 06, 2024

BUY
$92.27 - $101.54 $170,330 - $187,442
1,846 Added 20.56%
10,826 $1.09 Million
Q3 2023

Nov 03, 2023

BUY
$94.73 - $105.13 $18,567 - $20,605
196 Added 2.23%
8,980 $914,000
Q2 2023

Aug 04, 2023

BUY
$92.52 - $104.91 $63,746 - $72,282
689 Added 8.51%
8,784 $886,000
Q1 2023

May 01, 2023

SELL
$80.03 - $92.81 $3,201 - $3,712
-40 Reduced 0.49%
8,095 $744,000
Q4 2022

Feb 07, 2023

BUY
$75.55 - $92.52 $90,131 - $110,376
1,193 Added 17.19%
8,135 $738,000
Q3 2022

Nov 03, 2022

BUY
$74.61 - $87.26 $17,234 - $20,157
231 Added 3.44%
6,942 $528,000
Q2 2022

Aug 02, 2022

BUY
$80.52 - $93.75 $88,088 - $102,562
1,094 Added 19.48%
6,711 $568,000
Q1 2022

May 09, 2022

SELL
$80.11 - $90.62 $26,195 - $29,632
-327 Reduced 5.5%
5,617 $493,000
Q4 2021

Jan 26, 2022

SELL
$79.7 - $88.13 $1,354 - $1,498
-17 Reduced 0.29%
5,944 $520,000
Q3 2021

Nov 05, 2021

SELL
$81.78 - $95.14 $139,353 - $162,118
-1,704 Reduced 22.23%
5,961 $488,000
Q2 2021

Aug 13, 2021

BUY
$85.24 - $94.15 $61,798 - $68,258
725 Added 10.45%
7,665 $699,000
Q1 2021

May 10, 2021

BUY
$83.5 - $98.47 $19,121 - $22,549
229 Added 3.41%
6,940 $593,000
Q4 2020

Feb 05, 2021

SELL
$78.07 - $94.43 $12,491 - $15,108
-160 Reduced 2.33%
6,711 $634,000
Q3 2020

Nov 09, 2020

SELL
$82.14 - $91.0 $119,924 - $132,860
-1,460 Reduced 17.52%
6,871 $597,000
Q2 2020

Jul 31, 2020

BUY
$80.93 - $91.1 $6,069 - $6,832
75 Added 0.91%
8,331 $727,000
Q1 2020

Apr 24, 2020

SELL
$70.67 - $99.01 $37,949 - $53,168
-537 Reduced 6.11%
8,256 $681,000
Q4 2019

Feb 07, 2020

BUY
$84.35 - $95.37 $351,992 - $397,979
4,173 Added 90.32%
8,793 $832,000
Q3 2019

Nov 06, 2019

BUY
$85.54 - $94.26 $185,621 - $204,544
2,170 Added 88.57%
4,620 $401,000
Q2 2019

Aug 06, 2019

SELL
$75.4 - $92.8 $3,543 - $4,361
-47 Reduced 1.88%
2,450 $224,000
Q1 2019

May 15, 2019

SELL
$75.32 - $86.15 $12,503 - $14,300
-166 Reduced 6.23%
2,497 $240,000
Q4 2018

Feb 08, 2019

BUY
$73.66 - $82.02 $6,997 - $7,791
95 Added 3.7%
2,663 $228,000
Q3 2018

Nov 06, 2018

SELL
$66.94 - $77.43 $10,576 - $12,233
-158 Reduced 5.8%
2,568 $221,000
Q2 2018

Aug 08, 2018

SELL
$64.91 - $73.36 $57,704 - $65,217
-889 Reduced 24.59%
2,726 $206,000
Q1 2018

May 09, 2018

SELL
$70.39 - $84.15 $256,712 - $306,895
-3,647 Reduced 50.22%
3,615 $292,000
Q4 2017

Feb 13, 2018

BUY
$72.33 - $77.64 $279,049 - $299,535
3,858 Added 113.34%
7,262 $610,000
Q3 2017

Oct 31, 2017

BUY
$74.14 - $77.27 $26,912 - $28,049
363 Added 11.94%
3,404 $292,000
Q2 2017

Aug 07, 2017

BUY
N/A
3,041
3,041 $253,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $232B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Lincoln National Corp Portfolio

Follow Lincoln National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.